Javascript must be enabled to continue!
The glycosylphosphatidylinositol‐anchored CD59 protein stimulates both T cell receptor ζ/ZAP‐70‐dependent and ‐independent signaling pathways in T cells
View through CrossRef
AbstractThe glycosylphosphatidylinositol (GPI)‐anchored CD59 protein (human protectin) protects cells against complement‐induced lysis, binds to CD2 and also transduces activation signals within T cells. We have further examined the biochemical signals transduced by CD59 and addressed its role in regard to the CD3‐mediated signaling cascade. We show here that CD59 cross‐linking induces a time‐dependent activation of p56lck and of p70zap (ZAP‐70) in CD3‐positive Jurkat cells, leading to the stimulation of the T cell receptor ζ/ZAP‐70 signaling cascade and interleukin‐2 (IL‐2) synthesis. Cross‐linking of CD59 on peripheral T cells and thymocytes induces tyrosine phosphorylations identical to those seen in Jurkat cells and this is followed by lymphokine production and proliferation. In contrast, only activation of CD59‐associated p56lck occurs in CD3‐negative Jurkat cells, while IL‐2 production is impaired, consistent with the lack of ZAP‐70 tyrosine phosphorylation observed in these cells. CD59 triggers activation events even in the absence of CD3/T cell receptor expression in Jurkat cells. CD59 cross‐linking synergizes with sub‐optimal doses of phorbol ester for activation of the protein kinase C and of the p42mapk, as shown by in vitro phosphorylation of histone HIIIS and myelin basic protein, respectively, and leads to CD25 but not CD69 expression. In conclusion, at least two signaling pathways are triggered through CD59, the first one involving ZAP‐70 activation and leading to IL‐2 secretion and a second pathway observed in the absence of ZAP‐70 activation leading to CD25 expression. These two pathways are likely to be involved in the modulation of T cell activation by CD59 protein.
Title: The glycosylphosphatidylinositol‐anchored CD59 protein stimulates both T cell receptor ζ/ZAP‐70‐dependent and ‐independent signaling pathways in T cells
Description:
AbstractThe glycosylphosphatidylinositol (GPI)‐anchored CD59 protein (human protectin) protects cells against complement‐induced lysis, binds to CD2 and also transduces activation signals within T cells.
We have further examined the biochemical signals transduced by CD59 and addressed its role in regard to the CD3‐mediated signaling cascade.
We show here that CD59 cross‐linking induces a time‐dependent activation of p56lck and of p70zap (ZAP‐70) in CD3‐positive Jurkat cells, leading to the stimulation of the T cell receptor ζ/ZAP‐70 signaling cascade and interleukin‐2 (IL‐2) synthesis.
Cross‐linking of CD59 on peripheral T cells and thymocytes induces tyrosine phosphorylations identical to those seen in Jurkat cells and this is followed by lymphokine production and proliferation.
In contrast, only activation of CD59‐associated p56lck occurs in CD3‐negative Jurkat cells, while IL‐2 production is impaired, consistent with the lack of ZAP‐70 tyrosine phosphorylation observed in these cells.
CD59 triggers activation events even in the absence of CD3/T cell receptor expression in Jurkat cells.
CD59 cross‐linking synergizes with sub‐optimal doses of phorbol ester for activation of the protein kinase C and of the p42mapk, as shown by in vitro phosphorylation of histone HIIIS and myelin basic protein, respectively, and leads to CD25 but not CD69 expression.
In conclusion, at least two signaling pathways are triggered through CD59, the first one involving ZAP‐70 activation and leading to IL‐2 secretion and a second pathway observed in the absence of ZAP‐70 activation leading to CD25 expression.
These two pathways are likely to be involved in the modulation of T cell activation by CD59 protein.
Related Results
High Frequencies of Increased Interferon-γ-Producing and/or Skewed CD8+ T Lymphocyte Subfamilies in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).
High Frequencies of Increased Interferon-γ-Producing and/or Skewed CD8+ T Lymphocyte Subfamilies in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).
Abstract
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal hematological disorder affecting all hematopoietic lineages, which lack glycosylphosphatidyl...
Structural Determinants and Biochemical Characterization of LORELEI as a GPI-Anchored Protein
Structural Determinants and Biochemical Characterization of LORELEI as a GPI-Anchored Protein
Abstract
Glycosylphosphatidylinositol-anchored proteins play critical roles in plant development, reproduction, and environmental responses. Howe...
Estado nutricional y medidas antropométricas en escolares Zapotecas y no Zapotecas de Oaxaca, México
Estado nutricional y medidas antropométricas en escolares Zapotecas y no Zapotecas de Oaxaca, México
Introduction: Indigenous groups face discrimination and exclusion, which generates inequities in the field of health. In addition, they are nutritionally vulnerable, which affects ...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
The Roles of Wilms’ Tumor Gene Peptide-Specific Cytotoxic T Lymphocytes in Immunologic Pathophysiology of Paroxysmal Nocturnal Hemoglobinuria.
The Roles of Wilms’ Tumor Gene Peptide-Specific Cytotoxic T Lymphocytes in Immunologic Pathophysiology of Paroxysmal Nocturnal Hemoglobinuria.
Abstract
It is unclear how a paroxysmal nocturnal hemoglobinuria (PNH) clone expands and bone marrow failure (BMF) occurs in PNH patients, although an immunologic me...
GW24-e3829 The role of CD59 in mouse cerebral ischaemia-reperfusion injury
GW24-e3829 The role of CD59 in mouse cerebral ischaemia-reperfusion injury
Objectives
To investigate dynamic changes of complement regulatory protein CD59 expression and discuss its possible mechanisms. During cerebral ischaemia-reperfus...
Characterization of the Immune Impact of Daratumumab By Mass Cytometry in Multiple Myeloma
Characterization of the Immune Impact of Daratumumab By Mass Cytometry in Multiple Myeloma
Abstract
Background With the advent of antibodies targeted against CD38 the ability to determine which patients will respond and the mechanism by which such response...
Stem cells
Stem cells
What is a stem cell? The term is a combination of ‘cell’ and ‘stem’. A cell is a major category of living thing, while a stem is a site of growth and support for something else. In...

